Get access to our best features
Get Started
Subscribe
Israel-Hamas Conflict
Northern Lights
Mother's Day
Donald Trump
US Politics
Joe Biden
US Crime
Republican Party
Baseball
US Economy
Golf
US Immigration
Stormy Daniels
Get access to our best features
Get Started
Published 17 days ago

Angle agrees deal with Astrazeneca for tech to kill cancer cells

Summary by City AM
Biopsy company Angle has signed a supplier agreement with Astrazenaca to develop technology able to detect, target and kill cancer cells.  The targeted approach is more good news for cancer research – in February, Astrazenaca announced a new drug showing ‘highly impactful’ results in a lung cancer trial. Under the agreement, Angle will develop a novel technology for cancer detection using DNA damage response (DDR) tests.  In 2022, the DDR therap…

0 Articles

All
Left
Center
Right
City AMCity AM

Angle agrees deal with Astrazeneca for tech to kill cancer cells

Biopsy company Angle has signed a supplier agreement with Astrazenaca to develop technology able to detect, target and kill cancer cells.  The targeted approach is more good news for cancer research – in February, Astrazenaca announced a new drug showing ‘highly impactful’ results in a lung cancer trial. Under the agreement, Angle will develop a novel technology for cancer detection using DNA damage response (DDR) tests.  In 2022, the DDR therap…

17 days ago·London, United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

AstraZenecaAstraZeneca
United KingdomUnited Kingdom
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal